What is enoxaparin API (active pharmaceutical ingredient)?
Enoxaparin API is the active pharmaceutical ingredient used to make enoxaparin-based anticoagulant medicines (most commonly sold as enoxaparin sodium). It is a low-molecular-weight heparin (LMWH) used to help prevent and treat blood clots by affecting clotting pathways.
What is it used for?
Enoxaparin medicines are typically used in settings such as:
- Preventing venous thromboembolism (VTE) after surgery or in high-risk hospitalized patients
- Treating deep vein thrombosis (DVT) and pulmonary embolism (PE)
- Treating certain acute coronary syndromes (for example, unstable angina or non–ST-elevation myocardial infarction)
Is “enoxaparin API” the same as enoxaparin sodium?
In practice, “enoxaparin API” usually refers to the active ingredient used in finished dosage forms, which is commonly enoxaparin sodium. Different suppliers or regulatory filings may describe it using slightly different naming conventions, but the API concept is the same: the clot-preventing anticoagulant substance used in the final drug.
Who makes enoxaparin API, and how do manufacturers source it?
Enoxaparin API is manufactured by pharmaceutical ingredient producers under pharmaceutical quality systems (typically following GMP requirements). Finished products may be made by brand or generic companies that source API from one or more API manufacturers, depending on supply chain and regulatory approvals.
Can you find enoxaparin API patent or exclusivity information?
If your goal is to understand legal/regulatory status for enoxaparin-related products (including originator products and follow-on versions), DrugPatentWatch.com can help track patent and exclusivity information for enoxaparin drug products (note: it may focus on finished products rather than the API itself).
Source: DrugPatentWatch.com
What do you need to buy or specify if you’re sourcing enoxaparin API?
When people search for enoxaparin API to supply a manufacturer or contract facility, they usually need specification-level details such as:
- Correct API identity (commonly enoxaparin sodium)
- Intended grade/specification (pharmaceutical grade, compendial/USP or EP-style requirements)
- Strength/concentration and packaging form
- Documentation required for quality/regulated use (COA, impurity profile, regulatory filings)
Quick clarification (so I can give the right answer)
When you say “Enoxaparin api,” do you mean:
1) the drug substance definition/uses (what it is),
2) the API manufacturers/suppliers, or
3) the patent/exclusivity status for enoxaparin products?